EuBiologics Co., Ltd. Logo

EuBiologics Co., Ltd.

A biopharmaceutical company developing vaccines and offering CRMO services.

206650 | KO

Overview

Corporate Details

ISIN(s):
KR7206650004
LEI:
Country:
South Korea
Address:
서울특별시 강남구 도산대로 509 13층,15층, 서울특별시

Description

EuBiologics Co., Ltd. is a biopharmaceutical company focused on improving global public health through the development and supply of safe and effective vaccines. The company specializes in preventative vaccines against global pandemics and emerging infectious diseases, with a key product being its oral cholera vaccine. In addition to its vaccine pipeline, EuBiologics provides Contract Research and Manufacturing Organization (CRMO) services. These services cover the development and GMP-compliant production of mammalian cell and microbial-derived biopharmaceuticals, including protein-based therapeutics and antibodies. The company is committed to technological innovation and adhering to international standards to address global health challenges.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-13 00:00
반기보고서 (2025.06)
Korean 1.0 MB
2025-07-31 00:00
투자판단관련주요경영사항 (유티프씨주멀티도즈(수출용) 백신의 한국 품목허가 승인)
Korean 12.0 KB
2025-06-30 00:00
[기재정정]신규시설투자등(자율공시)
Korean 12.7 KB
2025-05-13 00:00
분기보고서 (2025.03)
Korean 845.5 KB
2025-05-02 00:00
기업설명회(IR)개최
Korean 7.0 KB
2025-04-15 00:00
단일판매ㆍ공급계약체결(자율공시)
Korean 8.9 KB
2025-04-07 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.2 KB
2025-04-07 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.9 KB
2025-04-07 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.2 KB
2025-04-01 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB
2025-03-26 00:00
정기주주총회결과
Korean 24.7 KB
2025-03-26 00:00
대표이사변경
Korean 10.5 KB
2025-03-18 00:00
감사보고서제출
Korean 18.7 KB
2025-03-18 00:00
사업보고서 (2024.12)
Korean 620.5 KB
2025-03-18 00:00
[기재정정]주주총회소집공고
Korean 255.4 KB

Automate Your Workflow. Get a real-time feed of all EuBiologics Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for EuBiologics Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for EuBiologics Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.